Sekhar Chakrabarti
Overview
Explore the profile of Sekhar Chakrabarti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
419
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Das D, Sengupta I, Sarkar N, Pal A, Saha D, Bandopadhyay M, et al.
BMC Infect Dis
. 2017 Jan;
17(1):76.
PMID: 28088184
Background: Toll like receptors (TLRs) play an important role in innate immunity and various studies suggest that TLRs play a crucial role in pathogenesis of hepatitis B virus (HBV) infection....
2.
Roy P, Chakrabarti S
Med J Armed Forces India
. 2016 Jun;
72(2):111-5.
PMID: 27257320
Background: HIV estimates for 2009 released by National AIDS Control Organization (NACO) reveals that 2.4 million people in India were living with HIV, 39% being female, 4.4% children and 82.4%...
3.
Panigrahi R, Sarkar N, Biswas A, Pal A, Saha D, Singh S, et al.
J Clin Exp Hepatol
. 2015 Mar;
4(3):202-8.
PMID: 25755561
Background: TNF-α promoter polymorphism has been known to be a potential predictive factor in patients with HBV infection. We therefore tried to investigate whether the TNF-α promoter polymorphism at position...
4.
Biswas A, Panigrahi R, Pal M, De B, Chakrabarti S, Ghosh M, et al.
J Clin Exp Hepatol
. 2015 Mar;
3(4):281-7.
PMID: 25755515
Background: Interleukin-1β (IL-1β) is an important member of the family of the proinflammatory cytokines that modulate outcome of hepatitis B virus (HBV) infection. Objectives: This study was designed to investigate...
5.
Pal A, Sarkar N, Saha D, Guha S, Saha B, Chakrabarti S, et al.
Antivir Ther
. 2015 Feb;
20(5):545-54.
PMID: 25654813
Background: Worldwide, frequent emergence of lamivudine (3TC)-resistant HBV mutants has been reported in HIV-HBV-coinfected patients during long-term antiretroviral therapy (ART) that contains 3TC as the sole anti-HBV drug. Three major...
6.
Saha K, Firdaus R, Biswas A, Mukherjee A, Sarkar K, Chakrabarti S, et al.
Infect Genet Evol
. 2014 Mar;
24:57-67.
PMID: 24650917
Intra venous drug users (IVDUs) are at high risk for hepatitis C virus (HCV) infection owing to their high rate of drug abuses. The north-eastern part of India has a...
7.
Saha D, Pal A, Biswas A, Panigrahi R, Sarkar N, Das D, et al.
PLoS One
. 2014 Mar;
9(2):e90432.
PMID: 24587360
Previously we reported that the exposure to hepatitis B virus (HBV) infection serves as a major threat among the treatment naive HIV infected population of eastern India. Hence, molecular characterization...
8.
Biswas A, Panigrahi R, Chandra P, Banerjee A, Datta S, Pal M, et al.
ScientificWorldJournal
. 2013 Dec;
2013:212704.
PMID: 24302857
A previous study from West Bengal documented very high rate of occult HBV infection (OBI) among the HBsAg negative blood donors. This study was aimed to characterize the OBI strains...
9.
Roy P, Chakrabarti S
Indian J Virol
. 2013 Dec;
23(3):286-93.
PMID: 24293815
We studied the prevalence and effects of host genetic polymorphisms for the three AIDS restriction genes (ARGs) namely CCR2-64I, SDF1-3'A and MCP1-2518 G/A for HIV infection and progression to AIDS...
10.
Bag P, Ojha D, Mukherjee H, Halder U, Mondal S, Chandra N, et al.
PLoS One
. 2013 Oct;
8(10):e77937.
PMID: 24167591
Herpes genitalis, caused by HSV-2, is an incurable genital ulcerative disease transmitted by sexual intercourse. The virus establishes life-long latency in sacral root ganglia and reported to have synergistic relationship...